Participants were followed from study entry until death, emigration, withdrawal or end of follow-up period.
Participants were followed from study entry through 2013, during which time 10 349 died.
Women were followed from study entry (1992 2000) until first breast cancer diagnosis, death, emigration, or end of the follow-up period.
All individuals were followed from study entry and censored at the date of emigration (n=52), 10 August 2010, or diagnosis of rheumatoid arthritis (n=183), whichever came first.
The women were followed from study entry through each of their IVF cycles until they had a live birth or discontinued treatment at the MGH Fertility Center.
Participants are followed from study entry until they have a live birth or discontinue treatment at the Massachusetts General Hospital (MGH) Fertility Center.
Subjects will be followed from trial entry until study completion (24 weeks study period).
Patients will be followed from trial entry until study completion (six month study period).
Patients were followed from the date of study entry until 30 September 2007 for up to 5 years.
Individuals were followed from 1st January 2004/enrolment in study, until the earliest of a new NADC, 1st February 2010, death or six months after the patient's last visit.
